SecBot SecBot
8-K ·Filed Aug 18, 2026

NNDM

Nano Dimension Ltd.
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago SEC0001193125-26-354738
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

The expiration of the exclusivity period without a definitive agreement removes a near-term M&A catalyst. Monitor for any future announcements regarding Infinite Epigenetics or other strategic transactions, but this filing alone does not warrant a trade.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.55
T+0 close · Aug 18, 2026 · via day close
Latest settled
−14.19%
T+60 · $1.33
Vs SPY
−12.15%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 18 $1.55entry
  2. T+1 · 3mo ago −1.29%α −1.50% · $1.53
  3. T+5 · 3mo ago −0.65%α −0.44% · $1.54
  4. T+20 · 2mo ago −0.65%α +0.34% · $1.54
  5. T+60 · 6d ago −14.19%α −12.15% · $1.33

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Nano Dimension appointed Nadav Kidron as an independent Class II director and disclosed that the 30-day exclusivity period under a non-binding term sheet with Infinite Epigenetics, Inc. expired on July 15, 2026, with no definitive agreement reached. The director appointment is a routine governance change, while the failed exclusivity period is a minor negative signal for the company's M&A strategy, but neither event is material enough to move the stock significantly.

Key Facts

  • Nadav Kidron appointed to the Board as a Class II independent director, effective August 16, 2026.
  • Kidron will serve on the Audit Committee and Compensation Committee.
  • The 30-day exclusivity period under the non-binding term sheet with Infinite Epigenetics, Inc. expired on July 15, 2026.
  • As of the filing date, the parties have not reached an agreement on the terms of a definitive agreement.

Financial Impact

No financial figures disclosed; the failed exclusivity period suggests a potential deal with Infinite Epigenetics has not materialized, but no deal value was ever stated.

Risk Factors

  • The failed exclusivity period may indicate a breakdown in negotiations with Infinite Epigenetics, reducing the likelihood of a near-term acquisition.
  • The new director appointment is routine and provides no immediate operational or financial catalyst.

Market Snapshot

Exchange
Nasdaq
Sector
Printed Circuit Boards
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Software & IT

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-354738
Document: 0001193125-26-354738-index-headers.html0001193125-26-354738
Document: 0001193125-26-354738-index.html0001193125-26-354738
Document: 0001193125-26-354738.txt0001193125-26-354738

Track record

35 reports on NNDM

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +10.47% at T+20 after the Apr 6, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today 8-K Neutral 4/10 Entry $1.25 Now $1.19 −4.80% settles Nov 17
  2. Nov 12, 20264d ago 8-K Bearish 5/10 Entry $1.26 to $1.24 Now $1.19 +5.56% ▲ +1.59% +1.22% vs SPY
  3. Nov 10, 20266d ago DEF 14A Neutral 4/10 Entry $1.33 to $1.26 Now $1.19 −10.53% ▼ −5.26% −4.91% vs SPY
  4. Nov 10, 20266d ago Press Release Neutral 3/10 Entry $1.33 to $1.26 Now $1.19 −10.53% ▼ −5.26% −4.91% vs SPY
  5. Nov 5, 202611d ago 8-K Neutral 5/10 Entry $1.32 to $1.34 Now $1.19 −9.85% ▲ +1.52% −0.85% vs SPY
  6. Nov 5, 202611d ago Press Release Neutral 5/10 No price data
  7. Nov 3, 202613d ago 144 Neutral 2/10 Entry $1.36 to $1.32 Now $1.19 −12.50% ▼ −2.94% −4.59% vs SPY
  8. Nov 2, 202614d ago 3 Neutral 3/10 Entry $1.36 to $1.32 Now $1.19 −12.50% ▼ −2.94% −4.59% vs SPY
  9. Oct 29, 202618d ago SC 13D/A Neutral 3/10 Entry $1.39 to $1.33 Now $1.19 −14.39% ▼ −4.32% −2.54% vs SPY
  10. Oct 26, 202621d ago 3 Neutral 3/10 Entry $1.43 to $1.42 Now $1.19 −16.78% ▼ −0.70% −1.04% vs SPY
Showing 10 of 35

US Market Status

Market Closed · Opens in 9h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 18, 2026